For the last several months, we waited for a full approval of a COVID-19 vaccine by the FDA. Finally, we have one. So, we look at marketing Comirnaty — an approved COVID vaccine.
What’s Next: Marketing Comirnaty — An Approved COVID Vaccine
On August 23, 2021, the U.S. FDA (Food and Drug Administration) granted full approval to the Pfizer-BioNTech coronavirus vaccine for people 16 and older. Thus, becoming the first COVID vaccine to move beyond emergency-use status in the United States.
From a marketing perspective, that means Pfizer-BioNTech may now engage in advertising. Not permitted under emergency use. That will raise company revenues. As well as encourage more people to get vaccinated.
Now that Pfizer received full approval from the Food and Drug Administration for its vaccine, consumers should expect an influx of marketing. Health care experts say ads for the Pfizer-BioNTech COVID-19 vaccine, marketed as Comirnaty, could hit TV airwaves soon.
Click the image to read more.